![Juan Estupinan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Juan Estupinan
Amministratore Delegato presso Vestaron Corp.
Profilo
Juan Estupinan is currently the President, Chief Executive & Financial Officer at Vestaron Corp.
He previously worked as the Manager-Finance Reporting at Naurex, Inc. and as the Controller, VP-Finance & Accounting at Aptinyx, Inc. Mr. Estupinan completed his undergraduate degree at Indiana University and holds an MBA from Kellogg School of Management.
Posizioni attive di Juan Estupinan
Società | Posizione | Inizio |
---|---|---|
Vestaron Corp.
![]() Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Amministratore Delegato | 01/02/2024 |
Precedenti posizioni note di Juan Estupinan
Società | Posizione | Fine |
---|---|---|
Naurex, Inc.
![]() Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Corporate Officer/Principal | - |
APTINYX | Comptroller/Controller/Auditor | - |
Formazione di Juan Estupinan
Indiana University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
APTINYX | Health Technology |
Aziende private | 2 |
---|---|
Naurex, Inc.
![]() Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
Vestaron Corp.
![]() Vestaron Corp. Chemicals: SpecialtyProcess Industries Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC. | Process Industries |
- Borsa valori
- Insiders
- Juan Estupinan